Average Co-Inventor Count = 1.85
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Dicerna Pharmaceuticals, Inc. (77 from 99 patents)
2. Genta Incorporated (5 from 31 patents)
3. Promega Biosciences, Inc. (5 from 6 patents)
4. Gen-probe, Inc. (4 from 811 patents)
5. Oasis Biosciences Incorporated (1 from 1 patent)
92 patents:
1. 12435336 - Compositions and methods for inhibiting LPA expression
2. 12252691 - Compositions and methods for inhibiting LPA expression
3. 12234456 - Compositions and methods for modulating APOC3 expression
4. 12084662 - Compositions and methods for modulating PNPLA3 expression
5. 12077756 - Extended dicer substrate agents and methods for the specific inhibition of gene expression
6. 11912996 - Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
7. 11873488 - Double-stranded nucleic acid inhibitor molecules modified with Tm-increasing nucleotides
8. 11873493 - Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
9. 11851658 - Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
10. 11773390 - Methods and compositions for the specific inhibition of Complement Component 5(C5) by double-stranded RNA
11. 11697812 - Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA
12. 11667918 - Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA
13. 11661604 - Methods and compositions for inhibiting expression of LDHA
14. 11634713 - Extended dicer substrate agents and methods for the specific inhibition of gene expression
15. 11597929 - Extended dicer substrate agents and methods for the specific inhibition of gene expression